Do not buy this injection, warns Drap
13 November, 2024 19:03
The Drug Regulatory Authority (DRAP) has banned the sale and use of the injectable Rhophylac 300 for blood disorders while taking action against the sale of fake imported drugs.
Drap has issued a product recall alert asking people to avoid using the human anti-D immunoglobulin drug ‘Rhophylac’. The sample label of the injection, manufactured by Swiss company CSL Behring, contains incorrect details.
The fake medicine has been reported by KP Drug Inspector and Pharma Company of Karachi, Rhophylac Injection is available in medicine markets across the country, however, two different batch numbers have been found on the packet of the injection sample. The batch number was found different in the barcode scan. .
According to Drap, anti-D-immunoglobulin is a commercial biological antibody, and it is taken from human blood plasma, it targets the patient’s red cells. The use of fake injection can prove to be very harmful to health.
The Drap alert states that the quality and efficacy of counterfeit drugs are unclear and should not be used.
Catch all the Health News, Breaking News Event and Trending News Updates on GTV News
Join Our Whatsapp Channel GTV Whatsapp Official Channel to get the Daily News Update & Follow us on Google News.
Must Read
